<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09345</article-id><article-id pub-id-type="doi">10.7554/eLife.09345</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology and Stem Cells</subject></subj-group></article-categories><title-group><article-title>Matrix metalloproteinase 14 is required for fibrous tissue expansion</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-32426"><name><surname>Taylor</surname><given-names>Susan H</given-names></name><aff><institution content-type="dept">Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences</institution>, <institution>University of Manchester</institution>, <addr-line><named-content content-type="city">Manchester</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37005"><name><surname>Yeung</surname><given-names>Ching-Yan Chloé</given-names></name><aff><institution content-type="dept">Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences</institution>, <institution>University of Manchester</institution>, <addr-line><named-content content-type="city">Manchester</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22703"><name><surname>Kalson</surname><given-names>Nicholas S</given-names></name><aff><institution content-type="dept">Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences</institution>, <institution>University of Manchester</institution>, <addr-line><named-content content-type="city">Manchester</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37006"><name><surname>Lu</surname><given-names>Yinhui</given-names></name><aff><institution content-type="dept">Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences</institution>, <institution>University of Manchester</institution>, <addr-line><named-content content-type="city">Manchester</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37007"><name><surname>Zigrino</surname><given-names>Paola</given-names></name><aff><institution content-type="dept">Department of Dermatology, Center for Molecular Medicine</institution>, <institution>University of Cologne</institution>, <addr-line><named-content content-type="city">Cologne</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-23364"><name><surname>Starborg</surname><given-names>Tobias</given-names></name><aff><institution content-type="dept">Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences</institution>, <institution>University of Manchester</institution>, <addr-line><named-content content-type="city">Manchester</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37008"><name><surname>Warwood</surname><given-names>Stacey</given-names></name><aff><institution content-type="dept">Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences</institution>, <institution>University of Manchester</institution>, <addr-line><named-content content-type="city">Manchester</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37009"><name><surname>Holmes</surname><given-names>David F</given-names></name><aff><institution content-type="dept">Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences</institution>, <institution>University of Manchester</institution>, <addr-line><named-content content-type="city">Manchester</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37010"><name><surname>Canty-Laird</surname><given-names>Elizabeth G</given-names></name><aff><institution content-type="dept">Department of Musculoskeletal Biology, Institute of Ageing and Chronic Disease, Faculty of Health and Life Sciences</institution>, <institution>University of Liverpool</institution>, <addr-line><named-content content-type="city">Liverpool</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37011"><name><surname>Mauch</surname><given-names>Cornelia</given-names></name><aff><institution content-type="dept">Department of Dermatology, Center for Molecular Medicine</institution>, <institution>University of Cologne</institution>, <addr-line><named-content content-type="city">Cologne</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-22376"><name><surname>Kadler</surname><given-names>Karl E</given-names></name><aff><institution content-type="dept">Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences</institution>, <institution>University of Manchester</institution>, <addr-line><named-content content-type="city">Manchester</named-content></addr-line>, <country>United Kingdom</country><email>karl.kadler@manchester.ac.uk</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1124"><name><surname>Krumlauf</surname><given-names>Robb</given-names></name><role>Reviewing editor</role><aff><institution>Stowers Institute for Medical Research</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>21</day><month>09</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e09345</elocation-id><supplementary-material><ext-link xlink:href="elife-09345-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>10</day><month>06</month><year>2015</year></date><date date-type="accepted"><day>20</day><month>09</month><year>2015</year></date></history><permissions><copyright-statement>© 2015, Taylor et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Taylor et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Type I collagen-containing fibrils are major structural components of the extracellular matrix of vertebrate tissues, especially tendon, but how they are formed is not fully understood. MMP14 is a potent pericellular collagenase that can cleave type I collagen <italic>in vitro</italic>. Here we show that tendon development is arrested in <italic>Scleraxis-Cre::Mmp14</italic> lox/lox mice that are unable to release collagen fibrils from plasma membrane fibripositors. In contrast to its role in collagen turnover in adult tissue, MMP14 promotes embryonic tissue formation by releasing collagen fibrils from the cell surface.  Notably, tendons grow to normal size and collagen fibril release from fibripositors occurs in <italic>Col-r/r</italic> mice that have a mutated collagen-I that is uncleavable by MMPs. Furthermore, fibronectin (not collagen-I) accumulates in tendons of <italic>Mmp14</italic>-null mice. We propose a model for cell-regulated collagen fibril assembly during tendon development in which MMP14 cleaves a molecular bridge tethering collagen fibrils to the plasma membrane of fibripositors.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Chicken</kwd><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: The care and use of all mice in this study was carried out in accordance with UK Home Office regulations, UK Animals (Scientific Procedures) Act of 1986 under the UK Home Office licence (PPL 40/3485). All animals were sacrificed by a Schedule 1 procedure by trained personnel. MMP14 KO mice were as described previously (Zhou et al., 2000). To generate mice in which MMP14 is ablated in tendon-lineage cells, we crossed mice expressing Cre recombinase under the control of Scleraxis (ScxCre; C57BL/6) (Blitz et al., 2013) with mice carrying the floxed exons (exons 2 to 4) of the MMP14 gene (MMP14-floxed; C57BL/6) (Zigrino et al., 2012). MMP13 KO embryos were a generous gift from Zena Werb (Stickens et al., 2004). MMP2 heterozygous mice were imported from RIKEN BioResource Center (GelAKO/RBRC00398; C57) (Itoh et al., 1997) and bred to homozygosity. Col-r/r mice were imported from Jackson Laboratory (B6;129S4-Col1a1tm1Jae/J) (Liu et al., 1995). X-ray analyses were performed as described previously (Yeung et al., 2014).</p></fn></fn-group></back></article>